Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Noninvasive monitoring of fetal development and the early detection of pregnancy-associated complications is challenging, largely due to the lack of information about the molecular spectrum during pregnancy. Recently, cell-free DNA in plasma was found to reflect the global nucleosome footprint and status of gene expression, and showed potential for noninvasive health monitoring during pregnancy.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective(s)</h3><p>We aimed to test the relationships between plasma cell-free DNA profiles and pregnancy biology, and evaluate the use of cell-free DNA profile as a non-invasive method for physiological and pathological status monitoring during pregnancy.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Study Design</h3><p>We used genome cell-free DNA sequencing data generated from non-invasive prenatal testing in a total of 2937 pregnant women. For each physiological and pathological conditions, features of cell-free DNA profile were identified using the discovery cohort, and support vector machines classifiers were built and evaluated using independent training and validation cohorts.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>We established nucleosome occupancy profiles at transcription start sites in different gestational trimesters, demonstrated the relationships between gene expression and cell-free DNA coverage at transcription start sites, and showed that the cell-free DNA profiles at transcription start sites represented the biological processes of pregnancy. In addition, using cell-free DNA data, nucleosome profiles of transcription factor binding sites were identified to reflect transcription factor footprint, which may help to reveal the molecular mechanisms underlying pregnancy. Finally, by using machine learning models on low coverage non-invasive prenatal testing data, we evaluated the use of cell-free DNA nucleosome profiles for distinguishing gestational trimesters, fetal gender, and fetal trisomy 21, and highlighted its potential utility for predicting physiological and pathological fetal conditions by using low coverage non-invasive prenatal testing data.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion(s)</h3><p>Our analyses profiled nucleosome footprints and regulatory networks during pregnancy and established a noninvasive, proof-of-principle methodology for health monitoring during pregnancy.</p>

A statistical investigation of parameters associated with low cell-free fetal DNA fraction in maternal plasma for noninvasive prenatal testing

Noninvasive Prenatal Screening of Fetal Aneuploidy without Massively Parallel Sequencing

Expanding the Scope of Non-invasive Prenatal Testing to Detect Fetal Chromosomal Copy Number Variations

Progress in Non-Invasive Prenatal Testing Failure Due to Less Cell-Free Fetal DNA

Experimental factors are associated with fetal fraction in size selection noninvasive prenatal testing

Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.

[Analysis to the failure rate and causes of noninvasive prenatal testing based on high-throughput sequencing].

Maternal and Fetal Factors Affecting Cell-Free Fetal DNA (cffDNA) Fraction: A Systematic Review

The Association between Low Fetal Fraction of Non-Invasive Prenatal Testing and Adverse Pregnancy Outcomes for Placental Compromise

Noninvasive fetal genotyping of single nucleotide variants and linkage analysis for prenatal diagnosis of monogenic disorders

Detection of Cell-Free Fetal DNA in Maternal Plasma for Noninvasive Prenatal Screening of Fetal Chromosomal Aneuploidies in Women of Advanced Maternal Age

Accuracy of fetal fraction measurements in a single‐nucleotide polymorphism‐based noninvasive prenatal test

Statistical Approach to Decreasing the Error Rate of Noninvasive Prenatal Aneuploid Detection Caused by Maternal Copy Number Variation

Reasons for failure of noninvasive prenatal test for cell‐free fetal DNA in maternal peripheral blood

Non-invasive Prenatal Testing Reveals Copy Number Variations Related to Pregnancy Complications

Maternal, neonatal, pregnancy outcome characteristics of pregnant women with high plasma cell-free DNA concentration in non-invasive prenatal screening: a retrospective analysis

Performance evaluation of noninvasive prenatal testing on 24 chromosomes in a cohort of 118,969 pregnant women in Sichuan, China

[Perspective Study of Non-Invasive Prenatal Testing Using Cell-Free Fetal DNA in High-Risk Population].

Utilizing non-invasive prenatal test sequencing data for human genetic investigation

Noninvasive inferring expressed genes and in vivo monitoring of the physiology and pathology of pregnancy using cell-free DNA

Low fetal fraction in cell-free DNA testing is associated with adverse pregnancy outcome: Analysis of a subcohort of the TRIDENT-2 study